Status:
COMPLETED
Colposcopic Impression in a Birth Cohort Previously Eligible for HPV-vaccination
Lead Sponsor:
Falu Hospital
Conditions:
HPV
Cervical Cancer
Eligibility:
FEMALE
22-26 years
Brief Summary
Women were invited to attend colposcopy within two-four months after a positive screening test (two consecutive screening tests indicating low-grade squamous intraepithelial lesions (LSIL) and HPV pos...
Detailed Description
To describe the source population, the overall number of invitations and tests taken in the region during the study period were retrieved from the Swedish National Cervical Screening Registry (NKCx), ...
Eligibility Criteria
Inclusion
- \- HPV-vaccinated women Women taking their first test within the organized cervical screening program at age 23 Women residing in one Swedish county
Exclusion
- Women who were hysterectomized, Women who died Women who moved
- \-
Key Trial Info
Start Date :
March 14 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04909814
Start Date
March 14 2018
End Date
December 31 2019
Last Update
June 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Falu Lasarett
Falun, Dalarna County, Sweden, 79172